TTT 3.70% 13.0¢ titomic limited

Ann: Repkon Titomic joint venture kicks-off with A$2.3m order, page-6

  1. 394 Posts.
    lightbulb Created with Sketch. 59
    Further trial before production. A good move anyway.

    The TKF 1000 will enable replication of previously validated processes (in Titomic's Melbourne Bureau) in the Facility as the next step towards commercialisation.
 
watchlist Created with Sketch. Add TTT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.